People searching astaxanthin benefits usually want two facts: which changes showed up in human trials, and which marketing claims go beyond the evidence. The studies cluster around skin moisture and elasticity, one screen-use visual task tested only as a three-carotenoid combination, and exercise-recovery blood markers. In the pooled analyses below, wrinkle depth and endurance did not show a statistically significant benefit. These trials did not establish treatment of a disease. A brand that wants a finished product to follow one of those findings specifies the source, the active amount, and the dosage form with an astaxanthin supplement manufacturer.
This is an evidence briefing. It is not personal medical advice, and the milligrams below are the amounts researchers used. They are not a recommended intake.
What the Trials Actually Found
Outcome people ask about | What the human evidence showed | What stayed unproven | Who was studied |
|---|---|---|---|
| Skin moisture and elasticity | A meta-analysis of randomized trials found improvements with oral astaxanthin versus placebo. Elasticity varied substantially between studies [2] | Wrinkle depth was not statistically significant. The average does not establish the same change for every formulation [2] | Mostly middle-aged adults; many skin trials enrolled healthy Japanese women, and commercial funding was common [1] |
| Screen-related eye–hand coordination | A daily softgel of 6 mg astaxanthin + 10 mg lutein + 2 mg zeaxanthin for 8 weeks improved coordination after screen use [3] | Smooth-pursuit eye movement did not show a clear benefit. The result belongs to the combination [3] | Healthy adults who regularly used screens [3] |
| Exercise-recovery markers | Across 24 randomized trials, creatine kinase was lower with astaxanthin. Lactate dehydrogenase also favored astaxanthin, with wide inconsistency between trials [4] | That analysis did not show a significant effect on malondialdehyde, interleukin-6, VO2max, time-trial performance, or maximal power [4] | Healthy participants and athletes [4] |
| Cognition and fatigue | One meta-analysis assessed accuracy and reaction time after 8–12 weeks [5] | The accuracy interval crossed zero, so that analysis did not show a significant effect. Reaction time did not change. Subjective fatigue rests on two trials [5] | 346 healthy adults across 11 trials [5] |
A standardized mean difference compares groups on a common scale. It is not a percent improvement. When a 95% confidence interval crosses zero, that analysis did not show a clear difference between groups. A statistically significant result still does not mean every person will notice a change.
How strong is the evidence? A pooled result is usually more informative than one small trial. It is still limited by the quality and size of the studies inside it, how much those studies disagree, and whether the outcome matters in daily life. A lower creatine kinase value is a biomarker change. It is not the same thing as better performance or a long-term health outcome. Laboratory antioxidant assays measure chemical activity under set conditions. They do not establish comparative clinical benefits, or prevention of disease, in people.
What Astaxanthin Is
Astaxanthin is a red xanthophyll carotenoid. In supplements it is usually obtained from the microalga Haematococcus pluvialis, which produces the pigment after environmental stress. The same molecule occurs in salmon, shrimp, and krill. It dissolves in fat, so the trials above delivered it in oil-based capsules, not as a water-soluble vitamin.
A meal of salmon contains astaxanthin. It does not reproduce the daily supplemental amounts used in the skin trials: about 3–6 mg in the studies Ng and colleagues summarized, and 4–12 mg in several of the trials later pooled by Zhou and colleagues. [1][2] Food, microalgae, and synthetic material are different sourcing questions. This article stays with what the human studies measured.
Skin Moisture, Elasticity, and Wrinkles
Skin is the benefit with the most clinical reading, and also the one most often overstated.
Ng and colleagues summarized 11 clinical studies. Six were randomized, double-blind, and placebo-controlled; the others were open-label. In the controlled trials, changes in texture, visible appearance, or moisture were reported at about 3–6 mg per day. Not every trial reported every endpoint, and the samples were small. Many enrolled healthy Japanese women, and commercial funding was common. [1] That review is a narrative summary. It is not the same analysis as the pooled numbers below.
Zhou and colleagues pooled oral randomized trials separately from open-label work. Moisture improved (standardized mean difference 0.53; 95% confidence interval 0.05 to 1.01). Elasticity improved (0.77; 0.19 to 1.35), and that estimate was inconsistent across trials. Wrinkle depth was not statistically significant (–0.26; –0.58 to 0.06; p = 0.11). [2] These are averages from the trials in that pool. They do not establish that every astaxanthin material or finished formula will produce the same change. The paper’s closing sentence still refers to reducing wrinkles. The wrinkle-depth analysis does not support that sentence.
One ultraviolet trial is often used to imply sun protection. Twenty-three healthy Japanese adults took 4 mg per day. After 9 weeks, the astaxanthin group had a higher minimal erythema dose and lost less moisture on irradiated skin than the placebo group. The sample-size plan came from a pilot of 10 people, and the authors include a Fujifilm affiliation. [6] The finding needs replication. The trial did not assess tanning or whitening, and a higher erythema dose in this test is not a sun-protection factor.
Zhou and colleagues described middle-aged adults, often around 40–50 years old, who already had dryness or wrinkles, with many measurements taken from autumn into winter. [2] A countdown such as “visible in 14 days” applies only if that finished product was tested on that schedule.
Many of the skin studies enrolled middle-aged Japanese women, while the exercise and cognition literature included broader groups of healthy adults. [1][4][5] Those enrollment patterns do not establish a sex-specific benefit. Claims about hormonal health, fertility, menopause, or male-only recovery would need trials built for those questions. These trials were not.
Eyes, Screens, and Macular Pigment
Astaxanthin is widely sold beside lutein for screen fatigue. The trial that reports a screen-related performance change did not test astaxanthin by itself.
Yoshida and colleagues randomized healthy screen users to a softgel containing 6 mg astaxanthin, 10 mg lutein, and 2 mg zeaxanthin, or to rice oil, once daily for eight weeks. At eight weeks, eye–hand coordination after screen use was better in the active group: about 21.5 seconds versus 22.5 seconds, and accuracy about 84% versus 77%. Smooth-pursuit eye movement did not show a clear benefit. Macular pigment optical density rose in the active group. [3] The study disclosed industry affiliations among its authors. [3]
Because the softgel combined three carotenoids, neither the coordination result nor the rise in macular pigment can be attributed to astaxanthin alone. The study does not establish that astaxanthin itself increased macular pigment. [3] The Age-Related Eye Disease Study 2 formula used vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin. Astaxanthin was not in that formula. [7] Evidence for one carotenoid combination should not be generalized to astaxanthin alone, or to prevention or treatment of an eye disease.
Exercise Recovery and Physical Performance
Two reviews overlap, and they do not answer the same question.
A 2026 systematic review of 24 randomized trials, searched through January 2026, separated recovery markers from performance. Within this review, the clearest pooled signal was for creatine kinase (standardized mean difference –0.45; 95% confidence interval –0.83 to –0.07). Lactate dehydrogenase also favored astaxanthin (–0.93; –1.39 to –0.48); the authors flagged substantial disagreement among trials, so that estimate needs caution. The analysis did not show a significant effect on malondialdehyde, interleukin-6, VO2max, time-trial performance, or maximal workload and power. [4]
An earlier meta-analysis of 11 randomized trials and 346 healthy adults reported positive signals under regular training: fat oxidation, standardized mean difference 2.56 (95% confidence interval 1.24 to 3.89), and a physical-performance pool of 0.62 (0.17 to 1.06). [5] An effect of that size, from a small literature, needs replication before it becomes a label. The two reviews should be read by endpoint. The earlier analysis reported signals for selected exercise-efficiency and performance measures alongside training. The 2026 review did not show a significant pooled benefit for VO2max, time-trial performance, or maximal workload and power. [4][5] Those findings do not combine into a general claim that astaxanthin improves athletic performance.
The 2024 paper also reported larger signals in exploratory subgroups, including daily amounts at or above 20 mg and programs longer than 12 weeks. [5] A subgroup is not a dose–response relationship and not a recommended serving. The published abstract’s interval for the longer-duration slice is internally inconsistent, so that interval is not quoted here. Skin trials used lower amounts. [1][2]
Fat oxidation during a training study is not a body-weight result. Weight change was not an endpoint those reviews established.
Cognition and Fatigue
The 2024 meta-analysis is one assessment of the human evidence on fatigue, motor function, and cognition, not a complete file. After 8–12 weeks, the pooled effect on cognitive accuracy was small (standardized mean difference 0.12; 95% confidence interval –0.02 to 0.26). Because the interval crosses zero, that analysis did not show a statistically significant effect. Reaction time did not show a significant effect (–0.08; –0.26 to 0.10). Subjective fatigue was a positive trend from two studies and needs more evidence. [5]
That record does not establish a benefit for dementia, depression, or clinical cognitive impairment. The trials did not assess those conditions.
How Long the Studies Lasted
Researchers assessed outcomes at predefined time points. Study duration indicates when those measurements were taken, not when an individual user should expect to notice a benefit.
Question | When the cited studies measured it |
|---|---|
| Skin moisture and elasticity | Often within trials lasting 4–16 weeks [1][2] |
| Minimal erythema dose in the small UV trial | 9 weeks [6] |
| Eye–hand coordination after screen use | 8 weeks, for the three-carotenoid softgel only [3] |
| Creatine kinase and performance endpoints | Mixed protocols in the 24-trial pool; the performance endpoints were not significant [4] |
| Cognitive accuracy | 8–12 weeks; the estimate did not show a significant effect [5] |
Age, baseline diet, the amount used in that trial, and the other ingredients in the capsule all sit between the average result and one person.
How to Read a Benefit Before It Becomes a Product
A label that cites this literature should match four facts: the endpoint that moved, whether other actives were in the capsule, who was enrolled, and the amount the researchers used. Moisture and elasticity are the skin averages that reached significance; wrinkle depth did not. [2] The screen-use result belongs to astaxanthin with lutein and zeaxanthin. [3] The 3–6 mg per day range is what Ng and colleagues associated with the skin studies they reviewed. [1] The exploratory subgroup at or above 20 mg per day is not a standard serving. [5]
A brand developing a product around these findings should verify the source, the active milligrams per serving, the other ingredients, and the dosage form before the claim is written.
Side effects, a regulatory safety assessment, and the serving that belongs on a given market’s label are separate questions from the endpoints above.
FAQ
Will astaxanthin make skin tan? The skin trials did not assess tanning. They measured moisture, elasticity, texture, and, in one small trial, redness after a controlled ultraviolet exposure. [1][2][6]
Is astaxanthin hundreds of times stronger than vitamin C? That comparison comes from laboratory antioxidant assays. Those assays do not establish comparative clinical benefits in people. [2][4]
Is astaxanthin the same as lutein? No. Lutein and zeaxanthin are macular carotenoids and were part of the AREDS2 formula; astaxanthin was not. [7] In the screen-use trial, macular pigment rose on a three-carotenoid capsule, so the change cannot be attributed to astaxanthin alone. [3]
Can salmon replace the amount used in the trials? Salmon contains astaxanthin. The skin studies Ng and colleagues reviewed used about 3–6 mg per day of supplemental astaxanthin. [1] A fish meal is a different exposure from that protocol.
Does astaxanthin treat wrinkles, macular degeneration, or dementia? The pooled oral trials did not show a significant change in wrinkle depth. [2] The eye trial did not assess macular degeneration. [3] The cognition analysis did not show a significant effect, and it did not assess dementia. [5]
Related
Technical and Regulatory References
- Ng QX, De Deyn MLZQ, Loke W, Foo NX, Chan HW, Yeo WS. Effects of astaxanthin supplementation on skin health: a systematic review of clinical studies. J Diet Suppl. 2021;18(2):169-182. https://doi.org/10.1080/19390211.2020.1739187 · https://pubmed.ncbi.nlm.nih.gov/32202443/
- Zhou X, Cao Q, Orfila C, Zhao J, Zhang L. Systematic review and meta-analysis on the effects of astaxanthin on human skin ageing. Nutrients. 2021;13(9):2917. https://doi.org/10.3390/nu13092917 · https://pubmed.ncbi.nlm.nih.gov/34578794/
- Yoshida K, Sakai O, Honda T, Kikuya T, et al. Effects of astaxanthin, lutein, and zeaxanthin on eye–hand coordination and smooth-pursuit eye movement after visual display terminal operation in healthy subjects: a randomized, double-blind placebo-controlled intergroup trial. Nutrients. 2023;15(6):1459. https://doi.org/10.3390/nu15061459 · https://pubmed.ncbi.nlm.nih.gov/36986186/
- The effects of astaxanthin supplementation on exercise recovery biomarkers and exercise performance: a systematic review and meta-analysis. 2026. PubMed PMID: 42197030. https://pubmed.ncbi.nlm.nih.gov/42197030/
- Liu C, Dong X, Jia J, Ha M. Effects of astaxanthin supplementation on fatigue, motor function and cognition: a meta-analysis of randomized controlled trials. Biol Res Nurs. 2024;26(3):469-480. https://doi.org/10.1177/10998004241227561 · https://pubmed.ncbi.nlm.nih.gov/38243785/
- Ito N, Seki S, Ueda F. The protective role of astaxanthin for UV-induced skin deterioration in healthy people—a randomized, double-blind, placebo-controlled trial. Nutrients. 2018;10(7):817. https://doi.org/10.3390/nu10070817
- National Eye Institute. Age-Related Eye Disease Studies (AREDS/AREDS2). National Institutes of Health. https://www.nei.nih.gov/research/clinical-trials/age-related-eye-disease-studies-aredsareds2
Disclaimer
Educational reference only. Not intended to diagnose, treat, cure, or prevent any disease. Dietary supplements are not drugs. Study amounts are not recommended intakes. Structure/function wording and serving limits vary by country. Brand owners remain responsible for the finished label. KS Nutripharma manufactures to an agreed specification and does not approve claims.
Written by the KS Nutripharma formulation team | Reviewed for ingredient identity and claim boundaries, not as a clinical medical review | Updated October 12, 2026
Team background: KS Nutripharma
